MIRA•benzinga•
EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga Co. Announces Approval And Initiation Of Phase I Clinical Trial For Ketamin-2 In Neuropathic Pain
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 4, 2025 by benzinga